Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Neurovance
43 Thordike Street, Suite S1 3
Cambridge, MA 2141
Phone: 617-758-0300
www.neurovance.com

Neurovance has been spun out of Euthymics Bioscience, Inc. to advance EB-1020, a norepinephrine and dopamine-preferring reuptake inhibitor for ADHD. In addition to EB-1020, Neurovance also holds a substantial portfolio of research stage reuptake inhibitors.

Key Contact
Name
Anthony McKinney
Title
CEO
Funding Events

Date
Amount
Type
Investors
10/18/12 $7,000,000 Series A-1 Novartis Venture Funds
04/03/14 $6,300,000 Series A-1 Extension GBS Venture Partners
H&Q Healthcare Investors
H&Q Life Sciences Investors
Novartis Venture Funds
State of Wisconsin Investment Board
Venture Investors


Featured Reading